Status:
COMPLETED
Psychotherapy of Generalized Anxiety Disorder
Lead Sponsor:
German Research Foundation
Conditions:
Anxiety Disorders
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the effects of worry exposure with the effects of applied relaxation in patients with generalized anxiety disorder.
Detailed Description
Controlled treatment studies show that there is a lower efficacy of cognitive-behavioral treatment of generalized anxiety disorder (GAD) than in other anxiety disorders. The best effect sizes are foun...
Eligibility Criteria
Inclusion
- Primary Diagnosis of generalized anxiety disorder (according to impairment)
- 18-70 years of age
- Informed consent
Exclusion
- Not able to understand and speak the German language
- Acute, unstable and severe somatic disease (DSM-IV, Axis III)
- History of schizophrenia or bipolar disorder
- Other mental disorders requiring treatment
- Substance dependence within the past 12 months preceding treatment
- Personality disorders that interfere with treatment compliance
- Participation in any other psychotherapeutic interventions
- Use of anxiolytics (e.g. tranquilizer, hypnotics, neuroleptics; does not include stabile use of antidepressants)
Key Trial Info
Start Date :
October 1 2001
Trial Type :
INTERVENTIONAL
End Date :
July 1 2006
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00118001
Start Date
October 1 2001
End Date
July 1 2006
Last Update
April 1 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Technische Universität Dresden
Dresden, Germany, 01187